Hashim Ahmed takes us through the COMPARE study – presented at NCRI 2018 – which showed that men with localized prostate cancer are willing to accept lower survival odds for a better quality of life. He outlines the key findings, the implications of the results for physicians, and the next steps for research.

Find more on Medicine Matters oncology

This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on November 15, 2018.